Artiman Ventures: Big Data in drug Discovery
Artiman ventures and the team reviews the big data in drug discovery. Ajit Si...
Upcoming SlideShare
Loading in …5
×

Artiman Ventures - Reviews on big data

358 views

Published on

Read this extract where Artiman Ventures reviews the big data in drug discovery. Ajit Singh, CEO of Biomalgene, accomplice of Artiman Ventures tries to comprehend this activity with other board members from regarded social insurance organizations. To know more, go to www.artiman.com

Published in: Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
358
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Artiman Ventures - Reviews on big data

  1. 1. Artiman Ventures: Big Data in drug Discovery Artiman ventures and the team reviews the big data in drug discovery. Ajit Singh, previous CEO of Biolmagene, accomplice of Artiman Ventures tries to comprehend this activity with other board parts from regarded social insurance organizations. From Google tracking flu outbreaks via search behavior to companies seeking to reposition drugs based on in silico analysis, samples flourish of medicinal services being influenced by Big Data. At the same time dissimilar to most markets effectively handled by Big Data, life sciences markets are heavily regulated and traditional methods are deeply entrenched. Still, Big Data is making advances. We talk about the effect of information dissection on pill disclosure, VC venture and medicinal services

×